Capolongo, Stefano
Politecnico di Milano,
Italy
2025 Rank: 129337
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 2498 out of 217955 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 129337 | 122852 |
| Total Cites | 499 | 599 |
| H-index | 12 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 89 | 110 |
| Number of Single+First+Last Authored Papers | 123 | 123 |
| Total Cites to Single+First+Last Authored Papers | 372 | 445 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 401 | 431 |
| Ratio of Total Citations to Distinct Citing Papers | 1.24 | 1.39 |
| Self-Citation Percentage |
16.69%
|
|
Capolongo, Stefano
Politecnico di Milano,
Italy
2024 Rank: 151129
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Toxicology
Rank in SubField 1: 3198 out of 204759 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 151129 | 75649 |
| Total Cites | 433 | 668 |
| H-index | 10 | 12 |
| Hm-index | 4 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 2 | 4 |
| Number of Single+First Authored Papers | 29 | 29 |
| Total Cites to Single+First Authored Papers | 84 | 144 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 344 | 531 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 360 | 406 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.65 |
| Self-Citation Percentage |
35.18%
|
|
Capolongo, Stefano
Politecnico di Milano,
Italy
2023 Rank: 157820
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Toxicology
Rank in SubField 1: 3580 out of 190396 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157820 | 130951 |
| Total Cites | 454 | 579 |
| H-index | 10 | 11 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 107 | 139 |
| Number of Single+First+Last Authored Papers | 98 | 98 |
| Total Cites to Single+First+Last Authored Papers | 372 | 466 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 363 | 394 |
| Ratio of Total Citations to Distinct Citing Papers | 1.25 | 1.47 |
| Self-Citation Percentage |
21.59%
|
|
Capolongo, Stefano
Politecnico di Milano,
Italy
2022 Rank: 188518
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Toxicology
Rank in SubField 1: 4401 out of 175943 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 188518 | 140632 |
| Total Cites | 342 | 451 |
| H-index | 8 | 10 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 88 | 118 |
| Number of Single+First+Last Authored Papers | 88 | 88 |
| Total Cites to Single+First+Last Authored Papers | 288 | 363 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 283 | 324 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.39 |
| Self-Citation Percentage |
24.17%
|
|
Related Profiles
.jpg)
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.